# A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services

> **NCT01781806** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 328 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** emtricitabine 200mg/tenofovir 300mg

## Key facts

- **NCT ID:** NCT01781806
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2018-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781806, "A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01781806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*